Benjamin J. del Tito
Geen lopende functies
Loopbaan van Benjamin J. del Tito
Eerdere bekende functies van Benjamin J. del Tito
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Corporate Officer/Principal | 01-01-2005 | 01-01-2005 |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | 01-01-2003 | 01-01-2003 |
AAI, Inc.
 AAI, Inc. Specialty TelecommunicationsCommunications Part of TIS, Inc. (Japan), AAI, Inc. is an internet service provider. The private company is based in Tokyo, Japan. | Corporate Officer/Principal | 01-01-1999 | 01-01-1999 |
| AUXILIUM PHARMACEUTICALS, INC. | General Counsel | 01-10-2005 | - |
Opleiding van Benjamin J. del Tito
| Lehigh University | Doctorate Degree |
| Millersville University | Undergraduate Degree |
| University of Western Kentucky | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Japan | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Communications | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
AAI, Inc.
AAI, Inc. Specialty TelecommunicationsCommunications Part of TIS, Inc. (Japan), AAI, Inc. is an internet service provider. The private company is based in Tokyo, Japan. | Communications |
